Spironolactone "Mylan" 25 mg filmovertrukne tabletter Danija - danų - Lægemiddelstyrelsen (Danish Medicines Agency)

spironolactone "mylan" 25 mg filmovertrukne tabletter

mylan ab - spironolacton - filmovertrukne tabletter - 25 mg

Rifampar 150+75+400+275 mg filmovertrukne tabletter Danija - danų - Lægemiddelstyrelsen (Danish Medicines Agency)

rifampar 150+75+400+275 mg filmovertrukne tabletter

paranova danmark a/s - ethambutolhydrochlorid, isoniazid, pyrazinamidum, rifampicin - filmovertrukne tabletter - 150+75+400+275 mg

Paxlovid Europos Sąjunga - danų - EMA (European Medicines Agency)

paxlovid

pfizer europe ma eeig - nirmatrelvir, ritonavir - covid-19 virus infection - paxlovid is indicated for the treatment of coronavirus disease 2019 (covid-19) in adults who do not require supplemental oxygen and who are at increased risk for progressing to severe covid 19.

Kerendia Europos Sąjunga - danų - EMA (European Medicines Agency)

kerendia

bayer ag - finerenone - renal insufficiency, chronic; diabetes mellitus, type 2 - agenter, der virker på renin-angiotensinsystemet - kerendia is indicated for the treatment of chronic kidney disease (stage 3 and 4 with albuminuria) associated with type 2 diabetes in adults.

Perindoprilarginin "2care4" 10 mg filmovertrukne tabletter Danija - danų - Lægemiddelstyrelsen (Danish Medicines Agency)

perindoprilarginin "2care4" 10 mg filmovertrukne tabletter

2care4 aps - perindoprilarginin - filmovertrukne tabletter - 10 mg

Perindoprilarginin "Krka" 5 mg tabletter Danija - danų - Lægemiddelstyrelsen (Danish Medicines Agency)

perindoprilarginin "krka" 5 mg tabletter

krka d.d. novo mesto - perindoprilarginin - tabletter - 5 mg

Qaialdo Europos Sąjunga - danų - EMA (European Medicines Agency)

qaialdo

nova laboratories ireland limited - spironolacton - edema; heart failure; liver cirrhosis; ascites; nephrotic syndrome; hyperaldosteronism; essential hypertension - antihypertensives and diuretics in combination - in the management of refractory oedema associated with congestive cardiac failure; hepatic cirrhosis with ascites and oedema, malignant ascites, nephrotic syndrome, diagnosis and treatment of primary aldosteronism, essential hypertension. neonates, children and adolescents should only be treated under guidance of a paediatric specialist (see sections 5. 1 og 5.

Aqumeldi Europos Sąjunga - danų - EMA (European Medicines Agency)

aqumeldi

proveca pharma limited - enalapril (maleate) - hjertefejl - agenter, der virker på renin-angiotensinsystemet - treatment of heart failure.

Enahyton 20 mg/6 mg 20+6 mg tabletter Danija - danų - Lægemiddelstyrelsen (Danish Medicines Agency)

enahyton 20 mg/6 mg 20+6 mg tabletter

hexal ag - enalaprilmaleat, hydrochlorthiazid - tabletter - 20+6 mg

Entresto Europos Sąjunga - danų - EMA (European Medicines Agency)

entresto

novartis europharm limited - sacubitril, valsartan - hjertefejl - angiotensin ii antagonister, andre kombinationer, agenter handler på renin-angiotensin systemet - paediatric heart failureentresto is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction. adult heart failureentresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.